HealthLynked
Corp. Announces the Addition of Dan
Hall, VP of Arthrex, to
its Board of Directors and
Relocation
of Corporate
Headquarters to the
Arthrex Campus
Naples,
FL -- November 11, 2020 -- InvestorsHub NewsWire
-- HealthLynked
Corp. (OTCQB:
HLYK),
a global
healthcare network focused on care management of its members and a
provider of healthcare technologies that connects doctors, patients
and medical data, is pleased to
announce the addition of Dan
Hall, Arthrex Vice
President, as a Director,
effective immediately. The HealthLynked Board now has
six
members,
including three
independent
Directors. HealthLynked
is also
expanding
its
corporate headquarters and moving
to
commercial office
space in the Polaris building on the Arthrex
campus, in Naples,
Florida effective December 1,
2020.
Mr. Hall
is a Florida registered Certified Public Accountant and a member of
both the American Institute of Certified Public Accountants (AICPA)
and the Florida Institute of Certified Public Accountants
(FICPA).
Mr. Hall
began his career performing a wide variety of accounting services
for a wholly owned subsidiary of ConAgra. In 1995, Mr. Hall
transitioned into the medical device industry when he began working
for Arthrex, Inc., a world leader
in orthopedic surgical
device design, research, manufacturing and medical
education. He has held various
positions of increasing responsibility culminating in his current
role as Vice-President
of Shareholder Relations and Taxation, where he is
responsible for the
global enterprise's treasury, investment, financial audit, tax
strategy/compliance, and corporate structuring
activities.
In
addition to his role with Arthrex, Mr. Hall
is
also
Vice-President
of Krisdan Management, Inc. a Single-Family Office. In this
capacity, he
is
responsible for ultra-high net worth tax planning, strategy and
compliance, as well as trust and estate planning, investment
oversight, philanthropy and financial reporting.
Mr. Hall
earned a BS in Business Administration and Accounting from North
Dakota State University.
"I am
pleased to welcome Mr. Hall
to the
HealthLynked Board.
His
background
in finance, audit, tax,
M&A, and logistics will all be of great
value to the board as we continue
to
deliver
on our promise to improve healthcare for our patient
members. Mr Hall's
experience with
managing the rapid growth of Arthrex and his financial
expertise
will help guide how we grow
HealthLynked
through
M&A and expand our existing busineses
globally,"
stated HealthLynked's Chairman and CEO Michael Dent, MD.
"HealthLynked
has a outstanding
opportunity to expand its patient and physician
services globally, and
I am
confident I can help in a variety of
financial areas while
contributing
to the
growth of shareholder value,"
said Mr.
Hall
about
joining the HealthLynked Board of Directors.
About
HealthLynked Corp.
HealthLynked Corp.
provides a solution for both patient members and providers to
improve healthcare through the efficient exchange of medical
information. The HealthLynked Network is a cloud-based platform
that allows members to connect with their healthcare providers and
take more control of their healthcare. Members enter their medical
information, including medications, allergies, past surgeries and
personal health records, in one convenient online and secure
location, free of charge. Participating healthcare providers can
connect with their current and future patients through the system.
Benefits to in-network providers include the ability to utilize the
HealthLynked patent pending patient access hub "PAH" for patient
analytics. Other benefits for preferred providers include HLYK
marketing tools to connect with their active and inactive patients
to improve patient retention, access more accurate and current
patient information, provide more efficient online scheduling and
to fill last minute cancelations using the Company's "real time
appointment scheduling" all within its mobile application.
Preferred providers pay a monthly fee to access these HealthLynked
services. For additional information about HealthLynked Corp.,
please visit www.healthlynked.com and connect with HealthLynked on
Twitter, Facebook, and LinkedIn.
Forward
Looking Statements
Forward-Looking
Statements in this press release, which are not historical facts,
are forward-looking statements within the meaning of the Private
Securities Litigation Reform Act of 1995. Our actual results,
including as a result of any acquisitions, performance or
achievements may differ materially from those expressed or implied
by these forward-looking statements. In some cases, you can
identify forward-looking statements by the use of words such as
"may," "could," "expect," "intend," "plan," "seek," "anticipate,"
"believe," "estimate," "predict," "potential," "continue,"
"likely," "will," "would" and variations of these terms and similar
expressions, or the negative of these terms or similar expressions.
Such forward-looking statements are necessarily based upon
estimates and assumptions that, while considered reasonable by our
management, and us are inherently uncertain. We caution you not to
place undue reliance on any forward-looking statements, which are
made as of the date of this press release. We undertake no
obligation to update publicly any of these forward-looking
statements to reflect actual results, new information or future
events, changes in assumptions or changes in other factors
affecting forward looking statements, except to the extent required
by applicable laws. If we update one or more forward-looking
statements, no inference should be drawn that we will make
additional updates with respect to those or other forward-looking
statements. Certain risks and uncertainties applicable to our
operations and us are described in the "Risk Factors" section of
our most recent Annual Report on Form 10-K and in other filings we
have made with the U.S. Securities and Exchange Commission. These
reports are publicly available at www.sec.gov.
Contacts:
George
O'Leary
Chief
Financial Officer
goleary@healthlynked.com
(800)
928-7144, ext. 99
Investor
Relations Contacts:
Jim
Hock
Hanover
International Inc.
jh@hanoverintlinc.com
760-564-7400